Paulina Hill - Profile and Investment Details

Investor Profile

Paulina Hill is a Venture Capital based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Odyssey Therapeutics, Attenua, Syros Pharmaceuticals, Avilar TherapeuticsAttovia Therapeutics, Jounce Therapeutics, Hydrocision, Atea Pharmaceuticals, Zag Bio, Develogen AG, eTheRNA immunotherapies, LEXEO Therapeutics, Telesta Therapeutics, Prevail Therapeutics, Nuvation Bio, Editas Medicine, Ardana Bioscience, Orqis Medical, XTuit Pharmaceuticals, Scorpion Therapeutics, Alpine Immune Sciences, GelSight, Dicerna Pharmaceuticals, First Wave Bio, Morphic Therapeutic, Sana Biotechnology, Adagio Therapeutics, Intarcia Therapeutics, Eurobio-Scientific, Andrew Alliance, ImpactRx, BioSilta, Ikena Oncology, ESSA Pharma, Celletra, Median Technologies, Diagonal Therapeutics, Translate Bio, Omega Funds, CropDesign, CymaBay Therapeutics, Exenta, Inc., Neurotech, Aquarius Technologies, Replimune Group, Elixir Pharmaceuticals, Checkmate Pharmaceuticals, Imago BioSciences, Nuvig Therapeutics Inc., Icosavax, Visterra, SpineVision, Achaogen, OnPath Technologies, Amunix, Kronos Bio, Tisento Therapeutics, Immunic, Gossamer Bio, Anaconda BioMed, Kuros Biosciences, JenaValve Technology, Trevi Therapeutics, Egalet, Normunity, Paratek Pharmaceuticals, NextPoint Therapeutics, Inc., Arrakis Therapeutics, DBV Technologies, Kezar Life Sciences, Sienna Biopharmaceuticals, Oxagen, Evotec, Beam Therapeutics, Senti Biosciences, IFM Therapeutics, Chord Therapeutics, Endeavor BioMedicines, ObsEva, Arcutis Biotherapeutics, NeuroVision Imaging, . Over time, Paulina Hill has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Paulina Hill is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Drug Discovery, Genetics, Wellness, Women Founded, Rare Diseases, Healthcare Innovation, Life Science, Emerging Markets, Health Technology, Information Technology (IT), Diabetes, Business Development, Manufacturing, Biotechnology, Drug Development, Genomics, Innovation, Neuroscience, Clinical Trials, Digital Transformation, Research, Vaccines, Personalized Medicine, Mergers and Acquisitions, Social Impact, Digital Health, Developer Tools, Travel, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Molecular Diagnostics, Personal Health, Pharmaceuticals, Healthcare Technology, Acquisitions, Oncology may find it worthwhile to explore potential connections with Paulina Hill, as their portfolio suggests a familiarity and interest in this area.

Understanding Paulina Hill’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.